NASDAQ: HALO       Halozyme Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
28.31   -0.58 (2.01%)  27.97 - 28.86  380,216


Avg Volume (4 weeks):1,310,610
4 Weeks Range:25.70 - 31.64
4 Weeks Price Volatility (%):
52 Weeks Range:12.71 - 31.64
52 Weeks Price Volatility (%):
Average Price Target: 6.50
Price Target Upside/Downside: -21.81


No recent Headlines for this stock.

Business Background

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2060  3846  351  3139 

Top 10 Active Counters
 LK 1.38+1.38 
 BLRX 2.57+1.09 
 AAPL 108.956-6.364 
 NIO 30.83-1.16 
 OAS 0.155-0.014 
 SQQQ 25.075+1.715 
 TWTR 41.928-10.502 
 GE 7.370.00 
 HTZ 1.780.00 
 NOK 3.375+0.025